(ALKS) Alkermes - Performance 11.9% in 12m
Compare ALKS with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
55.95%
#9 in Group
Rel. Strength
70.23%
#2383 in Universe
Total Return 12m
11.91%
#40 in Group
Total Return 5y
64.55%
#24 in Group
P/E 12.7
52th Percentile in Group
P/E Forward 16.4
69th Percentile in Group
PEG -1,057.29
0th Percentile in Group
FCF Yield 9.78%
94th Percentile in Group
12m Total Return: ALKS (11.9%) vs XBI (-6.5%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
-8.25% | 25.2% | 163% | 11.9 | 10.6 | 1.43 | 83.8% | 78.5% |
HLN NYSE Haleon |
0.89% | 22.3% | 40.6% | 24.7 | 20.3 | 1.8 | 27.1% | - |
AMGN NASDAQ Amgen |
-11.6% | 4.69% | 33.7% | 36.6 | 13.3 | 0.94 | -18.8% | -20% |
LONN SW Lonza |
-1.09% | 7.58% | 35.2% | 60.7 | 31.7 | 1.15 | 12.6% | -10.3% |
BIM PA Biomerieux |
-2.83% | 12.9% | -1.51% | 31 | 24.2 | 1.45 | -58.7% | -25.1% |
KMDA NASDAQ Kamada |
-7.32% | 33% | -9.75% | 24.3 | 22.8 | 0.91 | 47.7% | 3.93% |
ERF PA Eurofins Scientific SE |
9.29% | -9.24% | 24.2% | 24.3 | 11.7 | 0.58 | -70.8% | -17.1% |
GRFS NASDAQ Grifols |
-7.23% | 11% | -64% | 26.9 | 11 | 0.23 | -45.4% | -33.9% |
Performance Comparison: ALKS vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ALKS
Total Return (including Dividends) | ALKS | XBI | S&P 500 |
---|---|---|---|
1 Month | -21.96% | -10.94% | -6.73% |
3 Months | -14.49% | -14.92% | -11.93% |
12 Months | 11.91% | -6.46% | 7.24% |
5 Years | 64.55% | -19.21% | 100.61% |
Trend Score (consistency of price movement) | ALKS | XBI | S&P 500 |
1 Month | -90.8% | -52.8% | -63.5% |
3 Months | -33.8% | -92.8% | -90.3% |
12 Months | 83.7% | -32.4% | 60.6% |
5 Years | 63.8% | -53.3% | 84.2% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #156 | -12.4% | -16.3% |
3 Month | #70 | 0.51% | -2.91% |
12 Month | #41 | 19.6% | 4.36% |
5 Years | #26 | 104% | -18.0% |
FAQs
Does ALKS Alkermes outperforms the market?
Yes,
over the last 12 months ALKS made 11.91%, while its related Sector, the SPDR S&P Biotech (XBI) made -6.46%.
Over the last 3 months ALKS made -14.49%, while XBI made -14.92%.
Over the last 3 months ALKS made -14.49%, while XBI made -14.92%.
Performance Comparison ALKS vs Indeces and Sectors
ALKS vs. Indices ALKS is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -2.04% | -15.2% | 4.26% | 4.67% |
US NASDAQ 100 | QQQ | -2.52% | -14.6% | 4.12% | 4.32% |
US Dow Jones Industrial 30 | DIA | -0.01% | -15.1% | 3.64% | 7.42% |
German DAX 40 | DAX | -3.26% | -18.0% | -15.6% | -8.42% |
Shanghai Shenzhen CSI 300 | CSI 300 | -1.47% | -18.6% | 3.11% | 2.70% |
Hongkong Hang Seng | HSI | -4.71% | -18.2% | -0.28% | -4.87% |
India NIFTY 50 | INDA | -4.19% | -24.0% | 0.91% | 8.92% |
Brasil Bovespa | EWZ | -6.31% | -22.4% | -0.79% | 20.7% |
ALKS vs. Sectors ALKS is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -2.75% | -15.1% | -4.87% | -3.16% |
Consumer Discretionary | XLY | -3.48% | -15.1% | -1.04% | 0.62% |
Consumer Staples | XLP | -2.19% | -24.9% | -3.70% | 0.58% |
Energy | XLE | -2.11% | -9.46% | 5.56% | 24.6% |
Financial | XLF | -2.74% | -17.1% | -4.61% | -5.92% |
Health Care | XLV | 0.23% | -14.2% | 6.48% | 14.3% |
Industrial | XLI | -1.44% | -15.9% | 4.43% | 7.85% |
Materials | XLB | -1.78% | -16.1% | 11.5% | 17.8% |
Real Estate | XLRE | -1.81% | -18.7% | 4.61% | -2.82% |
Technology | XLK | -2.31% | -13.0% | 10.5% | 10.8% |
Utilities | XLU | -1.93% | -22.2% | 0.63% | -9.77% |
Aerospace & Defense | XAR | -0.59% | -18.8% | -5.11% | -9.96% |
Biotech | XBI | -5.46% | -11.0% | 15.7% | 18.4% |
Homebuilder | XHB | -3.57% | -13.8% | 19.0% | 22.4% |
Retail | XRT | -3.91% | -16.6% | 7.70% | 18.2% |